NO20073774L - Terapeutiske forbindelser for intranasal administrering av ketorolac - Google Patents

Terapeutiske forbindelser for intranasal administrering av ketorolac

Info

Publication number
NO20073774L
NO20073774L NO20073774A NO20073774A NO20073774L NO 20073774 L NO20073774 L NO 20073774L NO 20073774 A NO20073774 A NO 20073774A NO 20073774 A NO20073774 A NO 20073774A NO 20073774 L NO20073774 L NO 20073774L
Authority
NO
Norway
Prior art keywords
compositions
ketorolac
intranasal administration
therapeutic compounds
nasally
Prior art date
Application number
NO20073774A
Other languages
English (en)
Inventor
Roger Whiting
Ramachandran Thirucote
Original Assignee
Roxro Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roxro Pharma Inc filed Critical Roxro Pharma Inc
Publication of NO20073774L publication Critical patent/NO20073774L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Terapeutiske sammensetninger, spesielt spraybare vandige sammensetninger, omfatter ketorolac eller et farmasøytisk akseptabelt salt, i kombinasjon med en lokalbedøvelse, så som lidokain hydroklorid. Sammensetningene blir nasalt administrert til en pasient med behov for det for å behandle smerte eller inflammasjon og har fordelen av redusert stikking og forbedret virksomhet, sammenlignet med kjente nasalt administrert sammensetninger.
NO20073774A 2004-12-23 2007-07-19 Terapeutiske forbindelser for intranasal administrering av ketorolac NO20073774L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63902204P 2004-12-23 2004-12-23
PCT/US2005/045883 WO2006071601A2 (en) 2004-12-23 2005-12-15 Therapeutic compositions for intranasal administration of ketorolac

Publications (1)

Publication Number Publication Date
NO20073774L true NO20073774L (no) 2007-09-05

Family

ID=36390269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073774A NO20073774L (no) 2004-12-23 2007-07-19 Terapeutiske forbindelser for intranasal administrering av ketorolac

Country Status (16)

Country Link
US (1) US20090042968A1 (no)
EP (1) EP1835911B1 (no)
JP (2) JP4966204B2 (no)
KR (1) KR20070091682A (no)
CN (1) CN101083984B (no)
AR (1) AR052347A1 (no)
AU (1) AU2005322305B2 (no)
CA (1) CA2587792C (no)
CR (1) CR9261A (no)
IL (1) IL183256A (no)
MX (1) MX2007007504A (no)
NO (1) NO20073774L (no)
NZ (1) NZ555247A (no)
SG (1) SG161208A1 (no)
WO (1) WO2006071601A2 (no)
ZA (2) ZA200704869B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2113246B1 (en) 2003-08-07 2016-06-22 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
CA2587792C (en) * 2004-12-23 2010-07-06 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
KR20110017433A (ko) * 2008-06-13 2011-02-21 록스로 파마 인코퍼레이티드 비강내 투여용 케토로락의 약학적 제형물
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8277781B2 (en) 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
CN102614122B (zh) * 2011-01-28 2013-10-16 上海现代药物制剂工程研究中心有限公司 酮咯酸氨丁三醇鼻腔喷雾剂及其制备方法
WO2012127497A1 (en) 2011-03-04 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of ketorolac or salts thereof
ME02958B (me) * 2011-05-13 2018-07-20 Euro Celtique Sa Intranazalni farmaceutski dozni oblici коji obuhvataju nalokson
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US9579257B2 (en) 2013-08-20 2017-02-28 Anutra Medical, Inc. Haptic feedback and audible output syringe
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
CN114191417A (zh) * 2021-12-17 2022-03-18 上海清芮科技有限公司 一种用于宠物的雾化吸入剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4778810A (en) * 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US4943587A (en) * 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US4885287A (en) * 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US6090368A (en) * 1998-03-03 2000-07-18 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
CA2587792C (en) * 2004-12-23 2010-07-06 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac

Also Published As

Publication number Publication date
AU2005322305A1 (en) 2006-07-06
IL183256A (en) 2011-02-28
ZA200704869B (en) 2009-02-25
EP1835911B1 (en) 2012-08-29
JP2009001586A (ja) 2009-01-08
EP1835911A2 (en) 2007-09-26
CA2587792A1 (en) 2006-07-06
SG161208A1 (en) 2010-05-27
KR20070091682A (ko) 2007-09-11
WO2006071601A3 (en) 2006-08-17
CA2587792C (en) 2010-07-06
AR052347A1 (es) 2007-03-14
IL183256A0 (en) 2007-10-31
CN101083984B (zh) 2010-11-10
CN101083984A (zh) 2007-12-05
AU2005322305B2 (en) 2010-09-16
NZ555247A (en) 2010-06-25
ZA200806671B (en) 2009-04-29
CR9261A (es) 2008-03-18
MX2007007504A (es) 2007-09-14
WO2006071601A2 (en) 2006-07-06
US20090042968A1 (en) 2009-02-12
JP2008525455A (ja) 2008-07-17
JP4966204B2 (ja) 2012-07-04

Similar Documents

Publication Publication Date Title
NO20073774L (no) Terapeutiske forbindelser for intranasal administrering av ketorolac
TW200603787A (en) Topical preparations containing ambroxol
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
NO20056252L (no) Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
MX2007005570A (es) Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos.
NO20065904L (no) Terapeutiske forbindelser
MXPA05004778A (es) Metodos de uso y composiciones que contienen compuestos inmunomoduladores para el tratamiento y manejo de enfermedades mieloproliferativas.
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
BR0315315A (pt) Método para tratar, prevenir ou controlar uma sìndrome mielodisplásica, método para reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de uma sìndrome mielodisplásica, composição farmacêutica, forma de dosagem unitária única, e, kit
IL189546A0 (en) Therapy for the treatment of disease
WO2005046318A3 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
WO2007126964A3 (en) Kinase inhibitors
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20100301L (no) Forbedrete brimonidinsammensetninger for behandling av erytem
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
HK1176318A1 (en) Injection device
MX2009011900A (es) Curacion de herida diabetica.
NZ595376A (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
MA32639B1 (fr) [4-(5-aminométhyl-2-fluoro-phényl)-pipéridin- 1-yl]-[7-fluoro-1- (2-méthoxy-éthyl)-4-trifluorométhoxy-1h-indol-3-yl]-méthanone en tant qu'inhibiteur de la tryptase de mastocytes
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
NO20065551L (no) Anvendelse av opoid reseptor antagonistforbindelser for forhindring og/eller behandling av sykdommer assosiert med malet calcineurin
TW200732304A (en) Piperidine derivatives
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application